SEAGEN INC's ticker is SGEN and the CUSIP is 81181C104. A total of 459 filers reported holding SEAGEN INC in Q2 2021. The put-call ratio across all filers is 0.46 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,285,019 | -70.6% | 34,339 | -73.3% | 0.00% | -75.0% |
| Q2 2023 | $24,780,187 | +71.6% | 128,755 | +80.6% | 0.01% | +33.3% |
| Q1 2023 | $14,438,540 | +39.0% | 71,312 | -11.8% | 0.01% | +20.0% |
| Q4 2022 | $10,385,793 | -47.5% | 80,817 | -44.1% | 0.01% | -44.4% |
| Q3 2022 | $19,789,000 | +9.4% | 144,622 | +41.5% | 0.01% | +12.5% |
| Q2 2022 | $18,081,000 | -46.7% | 102,186 | -56.6% | 0.01% | -27.3% |
| Q1 2022 | $33,904,000 | -11.2% | 235,362 | -4.6% | 0.01% | -8.3% |
| Q4 2021 | $38,159,000 | +38.9% | 246,821 | +52.6% | 0.01% | +20.0% |
| Q3 2021 | $27,464,000 | +9.8% | 161,738 | +2.0% | 0.01% | 0.0% |
| Q2 2021 | $25,023,000 | +93.4% | 158,499 | +70.1% | 0.01% | +66.7% |
| Q1 2021 | $12,939,000 | -67.4% | 93,178 | -58.9% | 0.01% | -70.0% |
| Q4 2020 | $39,747,000 | – | 226,940 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 46,912,266 | $8,300,656,000 | 47.09% |
| Eagle Health Investments LP | 262,502 | $46,447,000 | 10.83% |
| EcoR1 Capital, LLC | 1,008,628 | $178,467,000 | 6.16% |
| Lagoda Investment Management, L.P. | 49,460 | $8,751,000 | 5.80% |
| Redmile Group, LLC | 854,013 | $151,109,000 | 5.77% |
| Nan Fung Group Holdings Ltd | 47,096 | $8,333,000 | 5.72% |
| Atika Capital Management LLC | 282,500 | $49,985,000 | 5.62% |
| Avoro Capital Advisors LLC | 1,525,000 | $269,834,000 | 5.33% |
| Parkman Healthcare Partners LLC | 76,626 | $13,558,000 | 4.99% |
| Artal Group S.A. | 525,000 | $92,894,000 | 4.96% |